Yonglu Tian

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Extracorporeal Membrane Oxygenation

Allogeneic Hematopoietic Stem Cell Transplantation

Dna Damage Response

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

Nature communications

Journal of cell science

Peking University

Peking University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking University Jul 01 2019

China

Postdoctor :: School of Life Sciences

Peking University Jun 22 2008 - Sep 06 2014

China

Veterinarian :: Laboratory animal centre

Education History

Peking University Sep 06 2014 - Jul 01 2019

China

PHD :: Academy for Advanced Interdisciplinary Studies

China Agricultural University Apr 10 2010 - Dec 12 2012

China

MSC :: College of Animal Science and Technology

Agricultural University of Hebei Sep 01 2003 - Jun 22 2008

China

BSC :: College of Animal Science and Technology

Publications

Yuanjun Li, Yonglu Tian, Xiayuhe Pei, Pengli Zheng, Linqing Miao, Lingjun Li, Chunxiong Luo, Peixun Zhang, Bao-Guo Jiang, Junlin Teng, Ning Huang, Jianguo Chen
SCG10 is required for peripheral axon maintenance and regeneration in mice. Journal of cell science (2023)
Min Wei, Xinping Huang, Liming Liao, Yonglu Tian, Xiaofeng Zheng
SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in colon cancer. Cancer research (2023)
Kongjie Lu, Chenyang Li, Jiao Liu, Jinpeng Wang, Yongfeng Li, Bin He, Junzhao Li, Xiaochen Zhang, Mengping Wei, Yonglu Tian, Rong Zhang, Chen Zhang, Yong Zhang
Impairments in endogenous AMPA receptor dynamics correlates with learning deficits in Alzheimer's disease model mice. Proceedings of the National Academy of Sciences of the United States of America 120 (40) (2023)
Ruidan Xu, Shuyu Yu, Dan Zhu, Xinping Huang, Yuqi Xu, Yimin Lao, Yonglu Tian, Jinfang Zhang, Zefang Tang, Yuanyuan Zhang, Jing Yi, Hong Hu Zhu, Xiaofeng Zheng
hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy. Nature communications 10 (1) (2019)